Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-535-3 | CAS number: 29253-36-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Distribution and Excretion of Monoisopropylnaphthalene in Rats
- Author:
- Kojima S, Babasaki T, Kiyozumi M, Nakagawa M
- Year:
- 1 981
- Bibliographic source:
- Bull. Environ. Contam. Toxicol., 26, 626-633
Materials and methods
- Objective of study:
- distribution
- excretion
- metabolism
- Principles of method if other than guideline:
- Toxicokinetics study
- GLP compliance:
- no
Test material
- Reference substance name:
- Isopropylnaphthalene
- EC Number:
- 249-535-3
- EC Name:
- Isopropylnaphthalene
- Cas Number:
- 29253-36-9
- Molecular formula:
- C13H14
- IUPAC Name:
- 1-(propan-2-yl)naphthalene; 2-(propan-2-yl)naphthalene
- Details on test material:
- - Name of test material (as cited in study report): Monoisopropylnaphthalene (MIPN), isomer mixture [CAS no. 29253-36-9]
- Name of second comparative test material (as cited in study report): and 1-isopropylnaphthalene (1-IPN) [CAS no. 6158-45-8 / EC no. 228-177-1]
- Substance type: organic
- Isomers composition of MIPN isomer mixture: 60% 2-isoppropylnaphthalene, 40% 1-isopropylnaphthalene
plus 60% 2-isopropyl [14C]naphthalene, 40% 1-isopropyl[14C]naphthalene
- Specific activity (if radiolabelling): 5.65 µCi/mg
- Locations of the label (if radiolabelling): naphthalene ring
Test substances are obtained from Kureha Chemical Co., Tokyo
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS (Oral administration experiment)
- Weight at study initiation: 190 - 210 g
- Housing: Individual metabolism cages
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
TEST ANIMALS (In situ biliary excretion experiment)
- The bile duct of animals anesthetised with ethyl ether was cannulated with PE-10 tubing in order to collect bile fluid.
- Weight at study initiation: 170 - 220 g
- Housing: Individual in Bollman cages (after oral administration of MIPN-14C in olive oil)
- Diet: ad libitum
- Water: ad libitum
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Duration and frequency of treatment / exposure:
- single dose
Doses / concentrations
- Remarks:
- Doses / Concentrations:
Group 1: Single dose of MIPN-14C (6.25 µCi/kg bw) plus non-labelled MIPN (100mg/kg bw)
Group 2: Single dose of non-labelled 1-IPN (100mg/kg bw)
- No. of animals per sex per dose / concentration:
- 3 at each sampling time
- Control animals:
- no
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Distribution, excretion)
- Body fluids sampled: urine, faeces, bile, blood
- Examined tissues: Adipose, skin, liver, kidneys, brain, muscle, , spleen
- Time and frequency of sampling: Feces and urine were collected separately 24, 48, 72, and 96 hr after administration
- Animals treated with 14C-MIPN were sacrificed at 2, 4, 6, 12 and 24 hr after administration, and tissues were collected for analysis.
- Animals treated with 1-IPN were sacrificed at 2, 6, 12 and 24 hr after administration. and tissues were collected for analysis.
- Time and frequency of sampling of bile in the biliary excretion experiment: 2, 4, 6, 8, 24, and 48 hr after administration.
PREPARATION OF TISSUES AND ANALYSIS OF RADIOACTIVITY:
- Decoloration of 100 mg tissue by warming at 45°C (3-5 hr) with 0.3 ml H2O2 (30%)
- Dissolving by adding 1.2 ml NCS solubilizer and warming (45°C) for 5-6 hr.
- After neutralisation wtih 0.05 ml of glacial acetic acid 10 ml of PCS scintillation cocktail was added.
- Determination of radioactivity with a liquid scintillation counter
PREPARATION OF URINE AND BILE AND ANALYSIS OF RADIOACTIVITY:
- Differentiation of conjugated and unconjugated metabolites of MIPN-14C by extraction with chloroform after pH adjustment to 1.0 - 2.0.
- Determination of radioactivity of the chloroform and aqueous layer
PREPARATION OF FECES AND ANALYSIS OF RADIOACTIVITY:
- Aliquots of 100 mg of the dried and powdered faeces were oxidised (Tri-carb sample oxidizer) and 14-CO2 was trapped into Carbo-sorb carbon dioxide absorber.
- Permafluor V scintillation cocktail was added and counted in a liquid scintillation counter.
Recoveries of radioactivity was 80-85% with these procedures.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on distribution in tissues:
- Maximal levels of radioactivity in all tissues were reached after 4 h, except skin (6 h) and spleen (6 h). In blood the level kept nearly constant until 12 h after administration. Then levels decreased with time. The highest maximum level of radioactivity were found in adipose tissue followed in descending order by skin > liver, kidney >brain > spleen > muscle.
Maximal levels of 1-IPN in liver, kidney and adipose were reached after 2 - 6 h after administration (relative constant values in this interval). Then 1-IPN levels decreased with time. Maximum level in skin was reached after 6 h hours and then level decreased rapidly. Maximum 1-IPN concentration in brain, muscle and spleen as well in blood was measured after 2 h. Afterwards the levels decreased more or less rapidly.
The highest maximum 1-IPN concentration was found in adipose tissue followed in descending order by skin > liver, brain > kidney > spleen, muscle, blood.
- Details on excretion:
- More than 50% of the total dose of radioactivity was excreted after 24 h via urine. After 96 h 78% of the total dose was excreted via urine.
14% of total dose was excreted via faeces after 96 h.
The excretion of radioactivity in the bile fluid was approx. 60% of the total dose. In consideration of the result that faecal excretion is the minor route of excretion of radioactivity derived from MIPN-14C, it was concluded that enterohepatic circulation is important in the reabsorption of the metabolites excreted into the intestine via the bile.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Conjugated and non-conjugated metabolites were found by TLC, but not identified.
Any other information on results incl. tables
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): no bioaccumulation potential based on study results
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
